MX2007004371A - Formulaciones de 4-hidroxitamoxifen en gel. - Google Patents

Formulaciones de 4-hidroxitamoxifen en gel.

Info

Publication number
MX2007004371A
MX2007004371A MX2007004371A MX2007004371A MX2007004371A MX 2007004371 A MX2007004371 A MX 2007004371A MX 2007004371 A MX2007004371 A MX 2007004371A MX 2007004371 A MX2007004371 A MX 2007004371A MX 2007004371 A MX2007004371 A MX 2007004371A
Authority
MX
Mexico
Prior art keywords
hydroxy tamoxifen
gel formulations
tamoxifen gel
hydroxy
formulations
Prior art date
Application number
MX2007004371A
Other languages
English (en)
Inventor
Valerie Masini-Eteve
Original Assignee
Besins Int Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04292447A external-priority patent/EP1647271A1/en
Application filed by Besins Int Lab filed Critical Besins Int Lab
Publication of MX2007004371A publication Critical patent/MX2007004371A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se refiere a composiciones farmaceuticas y geles que contienen 4-hidroxitamoxifen, y a metodos para utilizarlos.
MX2007004371A 2004-10-14 2005-10-13 Formulaciones de 4-hidroxitamoxifen en gel. MX2007004371A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04292447A EP1647271A1 (en) 2004-10-14 2004-10-14 4-Hydroxy tamoxifen gel formulations
US63835904P 2004-12-23 2004-12-23
PCT/EP2005/011654 WO2006040196A1 (en) 2004-10-14 2005-10-13 4-hydroxy tamoxifen gel formulations

Publications (1)

Publication Number Publication Date
MX2007004371A true MX2007004371A (es) 2007-06-07

Family

ID=35501209

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007004371A MX2007004371A (es) 2004-10-14 2005-10-13 Formulaciones de 4-hidroxitamoxifen en gel.

Country Status (24)

Country Link
EP (1) EP1799201B1 (es)
JP (1) JP5047800B2 (es)
KR (1) KR101294947B1 (es)
AT (1) ATE415156T1 (es)
AU (1) AU2005293712B2 (es)
BR (1) BRPI0518139B1 (es)
CA (1) CA2582174C (es)
CY (1) CY1110499T1 (es)
DE (1) DE602005011314D1 (es)
DK (1) DK1799201T3 (es)
EA (1) EA011295B1 (es)
ES (1) ES2318563T3 (es)
GE (1) GEP20104889B (es)
HK (1) HK1103027A1 (es)
HR (1) HRP20090239T1 (es)
IL (1) IL182298A (es)
MA (1) MA28927B1 (es)
MX (1) MX2007004371A (es)
NO (1) NO338755B1 (es)
PL (1) PL1799201T3 (es)
PT (1) PT1799201E (es)
SI (1) SI1799201T1 (es)
TN (1) TNSN07139A1 (es)
WO (1) WO2006040196A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10080760B2 (en) * 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
KR101304536B1 (ko) * 2011-06-03 2013-09-24 전남대학교산학협력단 4-하이드록시 타목시펜 유사체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 간질환의 치료 또는 예방용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
AU2003296757A1 (en) * 2002-12-18 2004-07-09 Laboratoires Besins International Reduction of breast density with 4-hydroxy tamoxifen
MXPA05006526A (es) * 2002-12-18 2006-02-17 Besins Int Lab Tratamiento de mastalgia con 4-hidroxi tamoxifen.
EP1952810B1 (en) * 2003-04-01 2014-01-08 Besins Healthcare Luxembourg SARL Treatment of breast cancer with 4-hydroxytamoxifen
EP1694319B1 (en) * 2003-12-15 2008-07-16 Laboratoires Besins International Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia
EP1579856A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
US20050208139A1 (en) * 2004-03-22 2005-09-22 Ascend Therapeutics, Inc. Chemically stable compositions of 4-hydroxy tamoxifen
RU2357726C2 (ru) * 2004-03-22 2009-06-10 Лаборатуар Безен Энтернасьональ Лечение и профилактика доброкачественной опухоли груди 4-гидрокситамоксифеном

Also Published As

Publication number Publication date
PT1799201E (pt) 2009-02-26
EA200700834A1 (ru) 2007-10-26
DK1799201T3 (da) 2009-03-30
EP1799201B1 (en) 2008-11-26
GEP20104889B (en) 2010-02-10
HRP20090239T1 (en) 2009-06-30
CA2582174C (en) 2013-01-29
PL1799201T3 (pl) 2009-05-29
IL182298A (en) 2013-01-31
BRPI0518139A (pt) 2008-10-28
JP2008525316A (ja) 2008-07-17
IL182298A0 (en) 2007-07-24
WO2006040196A1 (en) 2006-04-20
SI1799201T1 (sl) 2009-06-30
NO20072463L (no) 2007-05-14
KR101294947B1 (ko) 2013-08-09
CY1110499T1 (el) 2015-04-29
JP5047800B2 (ja) 2012-10-10
EA011295B1 (ru) 2009-02-27
AU2005293712B2 (en) 2011-04-21
HK1103027A1 (en) 2007-12-14
DE602005011314D1 (de) 2009-01-08
TNSN07139A1 (en) 2008-11-21
MA28927B1 (fr) 2007-10-01
ES2318563T3 (es) 2009-05-01
NO338755B1 (no) 2016-10-17
ATE415156T1 (de) 2008-12-15
CA2582174A1 (en) 2006-04-20
AU2005293712A1 (en) 2006-04-20
EP1799201A1 (en) 2007-06-27
BRPI0518139B1 (pt) 2021-10-13
KR20070068366A (ko) 2007-06-29

Similar Documents

Publication Publication Date Title
IL249263A0 (en) Methods and systems for extracorporeal organ treatment
UA87335C2 (en) Gel composition of 4-hydroxytamoxifen
ATE432067T1 (de) Embolie-teilchen
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
SE0301653D0 (sv) Novel compounds
NO20091976L (no) Nye forbindelser
NO20092611L (no) Krystallinsk faststoff Rasagilin base
TW200716646A (en) (S)-N-methylnaltrexone
TW200732349A (en) Anti-OX40L antibodies and methods using same
TW200716088A (en) Formulations and methods for treating amyloidosis
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
WO2008110995A3 (en) Solubilizing system for volatile ingredients
TW200531686A (en) Pharmaceutical compositions
EA200700023A1 (ru) Разрыхляющаяся при пероральном приёме фармацевтическая композиция, содержащая рисперидон
TW200517144A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
MXPA05008902A (es) Soluciones de drogas en mentol.
AU2003219046A1 (en) Cationic polymers and the use thereof in cosmetic formulations
HK1103027A1 (en) 4-hydroxy tamoxifen gel formulations
TW200511987A (en) Topical composition
MX2007002814A (es) Geles de testosterona comprendiendo propilenglicol como mejorador de penetracion.
TW200505460A (en) Rosmarinic acid composition
MX2009009178A (es) Bis-fosforatos de bazedoxifeno.
EA200601117A1 (ru) Малеат ибопамина, способ его получения и фармацевтические композиции на его основе
BRPI0514737A (pt) composições de tocoferol e usos

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights